[
  {
    "ts": "2025-12-23T06:10:03+00:00",
    "headline": "Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return",
    "summary": "Why Bio-Techne Is Back on Investors Radar Bio-Techne (TECH) has been drifting after a tough year, but recent gains over the past 3 months suggest investors are rethinking the story as growth and profitability quietly improve. See our latest analysis for Bio-Techne. At around $58.96, Bio-Techne is still nursing a weak 1 year total shareholder return of roughly negative 18 percent. However, the 3 month share price return in the low double digits hints that sentiment is stabilizing as investors...",
    "url": "https://finance.yahoo.com/news/bio-techne-tech-revisiting-valuation-061003271.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "840004e2-6c69-30cf-962f-755787e3e115",
      "content": {
        "id": "840004e2-6c69-30cf-962f-755787e3e115",
        "contentType": "STORY",
        "title": "Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return",
        "description": "",
        "summary": "Why Bio-Techne Is Back on Investors Radar Bio-Techne (TECH) has been drifting after a tough year, but recent gains over the past 3 months suggest investors are rethinking the story as growth and profitability quietly improve. See our latest analysis for Bio-Techne. At around $58.96, Bio-Techne is still nursing a weak 1 year total shareholder return of roughly negative 18 percent. However, the 3 month share price return in the low double digits hints that sentiment is stabilizing as investors...",
        "pubDate": "2025-12-23T06:10:03Z",
        "displayTime": "2025-12-23T06:10:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-revisiting-valuation-061003271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-revisiting-valuation-061003271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:00:00+00:00",
    "headline": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
    "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
      "content": {
        "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
        "contentType": "STORY",
        "title": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
        "pubDate": "2025-12-23T12:00:00Z",
        "displayTime": "2025-12-23T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147",
          "originalWidth": 400,
          "originalHeight": 146,
          "caption": "BT Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZyjXugroCeu5vlW6wYuCXA--~B/aD0xNDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 400,
              "height": 146,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DPQWAvlZo522o8ucV.R5NA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T04:33:30+00:00",
    "headline": "3 of Wall Street’s Favorite Stocks That Concern Us",
    "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
    "url": "https://finance.yahoo.com/news/3-wall-street-favorite-stocks-043330900.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "018637e3-4453-3a89-b42c-047f6ee0c03b",
      "content": {
        "id": "018637e3-4453-3a89-b42c-047f6ee0c03b",
        "contentType": "STORY",
        "title": "3 of Wall Street’s Favorite Stocks That Concern Us",
        "description": "",
        "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
        "pubDate": "2025-12-23T04:33:30Z",
        "displayTime": "2025-12-23T04:33:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/d17093445523e316166faf5da5f36f75",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ACEL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/b0JhvVRlWnNOzW4P.O7.mg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/d17093445523e316166faf5da5f36f75.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9DkJJmJ_YaRUB4sRY3RTqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/d17093445523e316166faf5da5f36f75.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-wall-street-favorite-stocks-043330900.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-wall-street-favorite-stocks-043330900.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACEL"
            },
            {
              "symbol": "FNKO"
            },
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]